Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity

Zarouchlioti, C; Sanchez-Pintado, B; Hafford Tear, NJ; Klein, P; Liskova, P; Dulla, K; Semo, M; ... Davidson, AE; + view all Zarouchlioti, C; Sanchez-Pintado, B; Hafford Tear, NJ; Klein, P; Liskova, P; Dulla, K; Semo, M; Vugler, AA; Muthusamy, K; Dudakova, L; Levis, HJ; Skalicka, P; Hysi, P; Cheetham, ME; Tuft, SJ; Adamson, P; Hardcastle, AJ; Davidson, AE; - view fewer (2018) Antisense Therapy for a Common Corneal Dystrophy Ameliorates TCF4 Repeat Expansion-Mediated Toxicity. The American Journal of Human Genetics 10.1016/j.ajhg.2018.02.010 . (In press). Green open access

https://ift.tt/2GALQTc